← Leaderboards
Antonio Fojo
Basic Sciences
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsChemotherapyInterestTumorResistanceResponseMediatingClinicMalignant Neoplasm Of ProstateComplexBasePharmaceutical PreparationsAreaRenal Cell CarcinomaLaboratoriesOperative Surgical ProceduresClinical TrialsLeadResearch StudyCisplatinCell LineClinical OncologyConduct Clinical TrialsMalignant Neoplasm Of Thyroid
Grant awards (35)
Microtubule (MT) Interfering Agents (MTAs): Mechanisms of Action and Resistance$574,878
ZIA · FY2015 · CA · contact PI
Cancers with Unique Properties: Pheochromocytoma, Adrenal and Thyroid Cancer$557,970
ZIA · FY2015 · CA · contact PI
Clinical, Basic, Translational and Kinetic Studies of Drug Action and Resistance$557,970
ZIA · FY2015 · CA · contact PI
Microtubule (MT) Interfering Agents (MTAs): Mechanisms of Action and Resistance$558,718
ZIA · FY2014 · CA · contact PI
Cancers with Unique Properties: Pheochromocytoma, Adrenal and Thyroid Cancer$542,286
ZIA · FY2014 · CA · contact PI
Clinical, Basic, Translational and Kinetic Studies of Drug Action and Resistance$542,286
ZIA · FY2014 · CA · contact PI
Medical Oncology Fellowship Program$6,279,868
ZIE · FY2013 · CA · contact PI
Microtubule (MT) Interfering Agents (MTAs): Mechanisms of Action and Resistance$453,967
ZIA · FY2013 · CA · contact PI
Clinical, Basic, Translational and Kinetic Studies of Drug Action and Resistance$453,967
ZIA · FY2013 · CA · contact PI
Cancers with Unique Properties: Pheochromocytoma, Adrenal and Thyroid Cancer$378,305
ZIA · FY2013 · CA · contact PI
Medical Oncology Fellowship Program$6,318,483
ZIE · FY2012 · CA · contact PI
Cancers with Unique Properties: Pheochromocytoma, Adrenal and Thyroid Cancer$462,328
ZIA · FY2012 · CA · contact PI
Microtubule (MT) Interfering Agents (MTAs): Mechanisms of Action and Resistance$462,328
ZIA · FY2012 · CA · contact PI
Clinical, Basic, Translational and Kinetic Studies of Drug Action and Resistance$462,328
ZIA · FY2012 · CA · contact PI
Medical Oncology Fellowship Program$6,492,409
ZIE · FY2011 · CA · contact PI
Multidrug Resistance Mediated by P-glycoprotein$469,331
ZIA · FY2011 · CA · contact PI
Adrenocortical Cancer and Thyroid Carcinomas: Models with Unique Properties$469,331
ZIA · FY2011 · CA · contact PI
Microtubule (MT) Interfering Agents (MTAs): Mechanisms of Action and Resistance$391,109
ZIA · FY2011 · CA · contact PI
Medical Oncology Fellowship Program$5,952,865
ZIE · FY2010 · CA · contact PI
Microtubule (MT) Interfering Agents (MTAs): Mechanisms of Action and Resistance$595,287
ZIA · FY2010 · CA · contact PI
Adrenocortical Cancer and Thyroid Carcinomas: Models with Unique Properties$446,465
ZIA · FY2010 · CA · contact PI
Multidrug Resistance Mediated by P-glycoprotein$446,465
ZIA · FY2010 · CA · contact PI
Medical Oncology Fellowship Program$5,992,340
ZIE · FY2009 · CA · contact PI
Microtubule (MT) Interfering Agents (MTAs): Mechanisms of Action and Resistance$665,816
ZIA · FY2009 · CA · contact PI
Adrenocortical Cancer and Thyroid Carcinomas: Models with Unique Properties$369,897
ZIA · FY2009 · CA · contact PI
Multidrug Resistance Mediated by P-glycoprotein$369,897
ZIA · FY2009 · CA · contact PI
Medical Oncology Fellowship Program$5,199,880
Z01 · FY2008 · CA · contact PI
Microtubule (MT) Interfering Agents (MTAs): Mechanisms of Action and Resistance$1,035,251
Z01 · FY2008 · CA · contact PI
Adrenocortical Cancer and Thyroid Carcinomas: Models with Unique Properties$517,626
Z01 · FY2008 · CA · contact PI
Medical Oncology Fellowship Program$8,440,298
Z01 · FY2007 · CA · contact PI
Microtubule (MT) Interfering Agents (MTAs): Mechanisms of Action and Resistance$943,099
Z01 · FY2007 · CA · contact PI
Adrenocortical Cancer (ACC) and Thyroid Carcinomas: Models of Cancers with Uniqu$526,589
Z01 · FY2007 · CA · contact PI
Microtubule (MT) Interfering Agents (MTAs): Mechanisms o$0
Z01 · FY2006 · BC · contact PI
Microtubule (MT) Interfering Agents (MTAs): Mechanisms o$0
Z01 · FY2005 · BC
Microtubule Interfering Agents: Mechanisms of Action$0
Z01 · FY2004 · BC